Cdk Associates, L.L.C.
10% Owner

Cdk Associates, L.L.C. insider trades: Strongbridge Biopharma (SBBP) stock purchases

10% Owner, Strongbridge Biopharma Last trade Sep 18, 2020 18 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2017
4
Companies
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Cdk Associates, L.L.C. reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 18, 2020SBBP↑ Buy$3.3M
Nov 21, 2019MTEM↑ Buy$3.8M
Dec 27, 2018SBBP↑ Buy$197K
Dec 26, 2018MTEM↑ Buy$86K
Dec 21, 2018SBBP↑ Buy$943K
Sep 25, 2018MTEM↑ Buy$3.0M
Aug 8, 2018SBBP↑ Buy$1.8M
Jul 30, 2018SBBP↑ Buy$326K
Jul 27, 2018SBBP↑ Buy$1.9M
Jul 23, 2018SBBP↑ Buy$276K
Jul 16, 2018SBBP↑ Buy$56K
Jul 20, 2017KALA↑ Buy$3.2M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Cdk Associates, L.L.C.'s insider trades

Cdk Associates, L.L.C. is a 10% owner of Strongbridge Biopharma (SBBP). Since Jul 20, 2017, it has reported 12 open-market purchases worth $18.9M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (5 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SBBP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.